These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

147 related items for PubMed ID: 15040828

  • 21. Age, body mass index, and serum prostate-specific antigen correlate with bone loss in men with prostate cancer not receiving androgen deprivation therapy.
    Conde FA, Sarna L, Oka RK, Vredevoe DL, Rettig MB, Aronson WJ.
    Urology; 2004 Aug; 64(2):335-40. PubMed ID: 15302490
    [Abstract] [Full Text] [Related]

  • 22. Serum leptin and bone metabolism in HIV patients treated with highly active antiretroviral therapy.
    Madeddu G, Spanu A, Chessa F, Calia GM, Lovigu C, Mannazzu M, Falchi A, Sanna D, Mura MS, Madeddu G.
    Q J Nucl Med Mol Imaging; 2009 Jun; 53(3):290-301. PubMed ID: 18596668
    [Abstract] [Full Text] [Related]

  • 23. Osteoporosis in patients on long-term home parenteral nutrition: a longitudinal study.
    Cohen-Solal M, Baudoin C, Joly F, Vahedi K, D'Aoust L, De Vernejoul MC, Messing B.
    J Bone Miner Res; 2003 Nov; 18(11):1989-94. PubMed ID: 14606511
    [Abstract] [Full Text] [Related]

  • 24. [Influence of long-term highly active antiretroviral therapy on bone mineral density in HIV/AIDS patients].
    Su YB, Xie J, Han Y, Qiu ZF, Li YL, Song XJ, Yu W, Li TS.
    Zhonghua Yi Xue Za Zhi; 2012 May 08; 92(17):1155-8. PubMed ID: 22883000
    [Abstract] [Full Text] [Related]

  • 25. Evaluation of bone mineral density in Iranian HIV/AIDS patients.
    Badie BM, Soori T, Kheirandish P, Izadyar S, SeyedAlinagh S, Foroughi M, Rostamian A, Mohraz M.
    Acta Med Iran; 2011 May 08; 49(7):460-7. PubMed ID: 21960080
    [Abstract] [Full Text] [Related]

  • 26. [The impact of highly active antiretroviral therapy on bone mineral density in human immunodeficiency virus infected patients].
    Guo FP, Yu XB, Luo L, Han Y, Qiu ZF, Zuo LY, Li YL, Yu W, Li TS.
    Zhonghua Nei Ke Za Zhi; 2010 Aug 08; 49(8):649-52. PubMed ID: 20979781
    [Abstract] [Full Text] [Related]

  • 27. Factors associated with low bone mineral density in a Brazilian cohort of vertically HIV-infected adolescents.
    Schtscherbyna A, Pinheiro MF, Mendonça LM, Gouveia C, Luiz RR, Machado ES, Farias ML.
    Int J Infect Dis; 2012 Dec 08; 16(12):e872-8. PubMed ID: 23031418
    [Abstract] [Full Text] [Related]

  • 28. Different impact of NNRTI and PI-including HAART on bone mineral density loss in HIV-infected patients.
    Madeddu G, Spanu A, Solinas P, Babudieri S, Calia GM, Lovigu C, Mannazzu M, Nuvoli S, Piras B, Bagella P, Mura MS, Madeddu G.
    Eur Rev Med Pharmacol Sci; 2015 Dec 08; 19(23):4576-89. PubMed ID: 26698255
    [Abstract] [Full Text] [Related]

  • 29. Long-term use of protease inhibitors is associated with bone mineral density loss.
    Kinai E, Nishijima T, Mizushima D, Watanabe K, Aoki T, Honda H, Yazaki H, Genka I, Tanuma J, Teruya K, Tsukada K, Gatanaga H, Kikuchi Y, Oka S.
    AIDS Res Hum Retroviruses; 2014 Jun 08; 30(6):553-9. PubMed ID: 24494779
    [Abstract] [Full Text] [Related]

  • 30. Reduced bone mineral density in human immunodeficiency virus-infected patients and its association with increased central adiposity and postload hyperglycemia.
    Brown TT, Ruppe MD, Kassner R, Kumar P, Kehoe T, Dobs AS, Timpone J.
    J Clin Endocrinol Metab; 2004 Mar 08; 89(3):1200-6. PubMed ID: 15001610
    [Abstract] [Full Text] [Related]

  • 31. Increased abdominal visceral fat is associated with reduced bone density in HIV-infected men with lipodystrophy.
    Huang JS, Rietschel P, Hadigan CM, Rosenthal DI, Grinspoon S.
    AIDS; 2001 May 25; 15(8):975-82. PubMed ID: 11399979
    [Abstract] [Full Text] [Related]

  • 32. Prevalence and predictors of low bone mineral density and fragility fractures among HIV-infected patients at one Italian center after universal DXA screening: sensitivity and specificity of current guidelines on bone mineral density management.
    Mazzotta E, Ursini T, Agostinone A, Di Nicola AD, Polilli E, Sozio F, Vadini F, Pieri A, Trave F, De Francesco V, Capasso L, Borderi M, Manzoli L, Viale P, Parruti G.
    AIDS Patient Care STDS; 2015 Apr 25; 29(4):169-80. PubMed ID: 25692868
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Low bone mineral density, regardless of HIV status, in men who have sex with men.
    Grijsen ML, Vrouenraets SM, Wit FW, Stolte IG, Prins M, Lips P, Reiss P, Prins JM.
    J Infect Dis; 2013 Feb 01; 207(3):386-91. PubMed ID: 23148289
    [Abstract] [Full Text] [Related]

  • 35. The combination of FRAX and Ageing Male Symptoms scale better identifies treated HIV males at risk for major fracture.
    Pepe J, Isidori AM, Falciano M, Iaiani G, Salotti A, Diacinti D, Del Fiacco R, Sbardella E, Cipriani C, Piemonte S, Romagnoli E, Lenzi A, Minisola S.
    Clin Endocrinol (Oxf); 2012 Nov 01; 77(5):672-8. PubMed ID: 22630782
    [Abstract] [Full Text] [Related]

  • 36. CLINICAL Review # : low body weight mediates the relationship between HIV infection and low bone mineral density: a meta-analysis.
    Bolland MJ, Grey AB, Gamble GD, Reid IR.
    J Clin Endocrinol Metab; 2007 Dec 01; 92(12):4522-8. PubMed ID: 17925333
    [Abstract] [Full Text] [Related]

  • 37. Bone mineral loss through increased bone turnover in HIV-infected children treated with highly active antiretroviral therapy.
    Mora S, Sala N, Bricalli D, Zuin G, Chiumello G, Viganò A.
    AIDS; 2001 Sep 28; 15(14):1823-9. PubMed ID: 11579244
    [Abstract] [Full Text] [Related]

  • 38. Early loss of bone mineral density is correlated with a gain of fat mass in patients starting a protease inhibitor containing regimen: the prospective Lipotrip study.
    Bonnet E, Ruidavets JB, Genoux A, Mabile L, Busato F, Obadia M, Prévoteau F, Marchou B, Massip P, Marion-Latard F, Delpierre C, Bernard J, Perret B.
    BMC Infect Dis; 2013 Jun 28; 13():293. PubMed ID: 23809140
    [Abstract] [Full Text] [Related]

  • 39. Adverse bone health and abnormal bone turnover among perinatally HIV-infected Asian adolescents with virological suppression.
    Sudjaritruk T, Bunupuradah T, Aurpibul L, Kosalaraksa P, Kurniati N, Prasitsuebsai W, Sophonphan J, Sohn AH, Ananworanich J, Puthanakit T, Bone-D Study Group.
    HIV Med; 2017 Apr 28; 18(4):235-244. PubMed ID: 27477214
    [Abstract] [Full Text] [Related]

  • 40. Bone turnover markers in HIV disease.
    Haskelberg H, Carr A, Emery S.
    AIDS Rev; 2011 Apr 28; 13(4):240-50. PubMed ID: 21975360
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.